The largest database of trusted experimental protocols

Anti glyceraldehyde 3 phosphate dehydrogenase gapdh antibody

Manufactured by Merck Group
Sourced in United States

Anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody is a laboratory tool used to detect the presence and quantity of the GAPDH protein in biological samples. GAPDH is a key enzyme involved in glycolysis, the process of converting glucose into energy. This antibody can be used in various research applications, such as Western blotting, immunohistochemistry, and ELISA, to study GAPDH expression and its role in cellular processes.

Automatically generated - may contain errors

12 protocols using anti glyceraldehyde 3 phosphate dehydrogenase gapdh antibody

1

In vitro assay for ceramide synthase

Check if the same lab product or an alternative is used in the 5 most similar protocols
NBD-sphinganine and palmitoyl-CoA (C16-CoA) were from Avanti Polar Lipids (Alabaster, AL). Defatted-bovine serum albumin, a protease inhibitor cocktail and an anti-CerS6 antibody were from Sigma-Aldrich (St. Louis, MO). Horseradish peroxidase was from the Jackson Laboratory (Bar Harbor, ME). An enhanced chemiluminescence (ECL) detection system was from Cyanagen (Bologna, Italy). An anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody and silica gel 60 thin layer chromatography plates were from Merck (Billerica, MA). All solvents were of analytical grade and purchased from Bio-Labs (Jerusalem, Israel).
+ Open protocol
+ Expand
2

Colon Cancer Cell Line Culture and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon cancer cell lines SW48 and LIM1215 were obtained from Horizon Discovery (Cambridge, UK) and DS Pharma Biomedical (Osaka, Japan), respectively. SW48 cells were cultured in McCoy's 5A medium (Wako, Osaka, Japan) with 10% fetal bovine serum (FBS). LIM1215 cells were cultured in RPMI 1640 medium (Wako) with 10% FBS, 1 μg·mL−1 hydrocortisone (Sigma, St. Louis, MO, USA), 0.6 μg·mL−1 insulin (Thermo Fisher Scientific, Waltham, MA, USA), and 10 μm 1‐thioglycerol (Wako). Panitumumab was provided by Amgen, Inc. (Thousand Oaks, CA, USA). Cetuximab was purchased from Merck Serono (Darmstadt, Germany). FTD was purchased from Tokyo Chemical Industry (Tokyo, Japan). TPI was purchased from Biochempartner (Wuhan, China). Erlotinib was purchased from Selleck Chemicals LLC (Houston, TX, USA). U0126, LY294002, and SB203520 were purchased from Wako. Trametinib was purchased from Cayman Chemical Company (Ann Arbor, MI, USA). All antibodies used in the study were purchased from Cell Signaling Technology (Danvers, MA, USA), except anti‐glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) antibody (Merck Millipore, Billerica, MA, USA).
+ Open protocol
+ Expand
3

Western Blot Analysis of Osteogenic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
After protein extraction, protein concentration was determined with a BCA assay (CWBIO, China). A 10% SDS-PAGE gel was loaded with 20 µg of total protein, and the separated proteins were transferred by electroblotting to polyvinylidene fluoride (PVDF) membranes. The membranes were blocked with 5% non-fat dry milk in TBST (50mM tris-buffered saline, pH 7.6, 150mM NaCl, 0.1% Tween 20) and incubated with the primary antibody overnight at 4°C in 5% non-fat dry milk in TBST. Immunolabelling was detected using enhanced chemiluminescence (ECL) reagent (Thermo Fisher Scientific). The antibodies used for Western blot were from the following sources: anti-Runx2 antibody (Abcam, UK; 1:1,000), anti-Osx antibody (Cell Signalling Technology, USA; 1:1,000), anti-ALP antibody (Cell Signalling Technology; 1:1,000), anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (Sigma-Aldrich; 1:10,000).
+ Open protocol
+ Expand
4

Quantifying Cellular OCT Transporters in iPSC-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein expression levels of OCT-1, OCT-2 and OCT-3, encoded by the SLC22A gene family, facilitate metformin transport across cellular membranes (Nies et al., 2011 ). We tested OCT expression in iPSC-MSCs via Western blot analysis, as previously demonstrated (Patel, Younis, Ord, Basile, & Schneider, 2013 (link)). Briefly, after isolation of whole cell lysates, equal amounts of protein were separated by sodium dodecylsulphate-polyacrylamide gel electrophoresis, electrophoretically transferred on to polyvinylidene difluoride membranes. Membranes were incubated overnight at 4°C with rabbit antihuman OCT-1, OCT-2 and OCT-3 primary antibodies (Sigma, St. Louis, MO, USA), respectively. Blots were stripped and reprobed with an antiglyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (Sigma).
+ Open protocol
+ Expand
5

Western Blotting for GAS1 and GAPDH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described previously (van Roeyen et al., 2013 (link)). The following antibodies were used: anti-GAS1 antibody (1:100; Santa Cruz), anti-Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Antibody (1:3000; Sigma) was used as a loading control. The results were analyzed using Quantity One software (Bio-Rad, Richmond, Calif., USA).
+ Open protocol
+ Expand
6

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were lysed in RIPA buffer with protease inhibitors. Aliquotes of cell proteins (30 µg) were resolved on SDS-polyacrilamide gel and transferred to nitrocellulose membrane and then treated with anti-p53 (clone DO-1, Dako, Milan, Italy; diluted 1∶3000 in TBS-T), anti p21 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; diluted 1∶3000 in TBS-T), anti phospho-p38 (Cell Signaling Technology Inc., Danvers, MA, USA; diluted 1∶3000 in TBS-T), or anti IκB-alpha (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA; diluted 1∶1000 in TBS-T) overnight at 4°C. Horseradish-peroxidase-conjugated goat anti-mouse or anti-rabbit immuglobulins (Santa Cruz, Biotechnology Inc., Santa Cruz, CA, USA) were used as secondary antibodies. Antibodies complexes were visualized using the ECL Chemiluminescence Luminol Reagent (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). As a loading control, the blots were reprobed with an anti-β-tubulin or anti- glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (Sigma-Aldrich, Milan, Italy).
+ Open protocol
+ Expand
7

Protein Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were promptly homogenized in a homogenization buffer and centrifuged at 10,000×g for 30 min to collect the supernatant. Protein concentrations were determined with a BioRad protein assay (BioRad, Hercules, CA, USA). Total protein was separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. Membranes were washed, blocked, and incubated with anti-Nrdp1 antibody (1:1,000; Santa Cruz Biotechnology, CA, USA) and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1:1,000; Sigma). Membranes were washed and incubated with HRP-conjugated secondary antibodies (1:500; Santa Cruz Biotechnology). Proteins were detected using an enhanced chemiluminescence reagent (NEN, Boston, MA). The relative intensity of each band was determined using Image Lab 3.0 (BioRad Laboratories, Inc., Hercules, CA, USA).
+ Open protocol
+ Expand
8

Western Blot Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein from H20 and H446 SCLC cell lines was extracted by radioimmunoprecipitation and loading buffer and then boiled for 10 min until the samples were denatured. A 10% SDS-polyacrylamide gel was applied to separate the protein. Then the protein was transferred onto a nitrocellulose membrane (Life technologies, Carlsbad, CA, USA), and 5% milk in Tris-buffered saline containing 0.1% (v/v) Tween-20 (TBST) was used to block the membrane for 1 h at 37°C. Anti-hTERT antibody, anti-EZH2 antibody (Sigma, St. Louis, USA) and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) a ntibody (Sigma, St. Louis, USA), diluted by TBST at a concentration of 1:1000, were incubated with the membrane overnight at 4°C. The horse radish peroxidase secondary antibody (Sigma, St. Louis, USA), diluted by TBST at a concentration of 1:10 000, was incubated with the membrane after it was washed three times with TBST. An exposer (Thermo Fisher Labsystems, Waltham, MA, USA) was then used to display the protein bands. GAPDH served as the endogenous control.
+ Open protocol
+ Expand
9

Quantification of TRPA1 Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples (~1 g) of the distal colon and the spinal cord were extracted in three volumes of extract buffer, centrifuged at 13,000× g for 10 minutes at 4°C; the supernatant was saved at −70°C until usage. Western blotting protocol was developed for the Bio-Rad protein gel and transfer apparatus. The membranes were blocked and incubated with the primary antibodies at 4°C, overnight, and subsequently with the secondary antibodies for 2 hours. The gel was transferred to a polyvinylidene difluoriizde membrane and blotted with primary (overnight) and then with secondary (1 hour) antibodies. The primary antibodies included a rabbit polyclonal anti-TRPA1 antibody (1:200; Novus Biologicals) and a mouse monoclonal anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1:500; Sigma). The secondary antibodies included anti-mouse Ig for GAPDH (1:1,000) and anti-rabbit Ig for TRPA1 (1:3,000). The integrated density of Western blotting bands was quantitatively analyzed by the Gel Image analysis software. TRPA1 protein expression was normalized to GAPDH.
+ Open protocol
+ Expand
10

Quantitative Western Blot Analysis of Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cellular protein was prepared as described previously [29 (link)], and the protein concentration was measured using Quick Start Bradford Reagent (Bio-Rad, Hercules, CA, USA). Twenty micrograms of protein was subjected to sodium dodecyl sulfate polyacrylamide electrophoresis (SDS-PAGE) in a 4 to 20% gradient gel (Bio-Rad), and the blot was transferred onto a polyvinylidene difluoride membrane by iBlot 2 (Life Technologies, Carlsbad, CA, USA). After blocking with 0.2% nonfat dry milk (Cell Signaling Technology, Danvers, MA, USA) in Tris-buffered saline (Takara Bio), the membrane was incubated with the primary antibodies (anti-TPD52 antibody (1/1,000 dilution; Abcam, Branford, CT, USA), anti-TPD54 antibody (1/1,000 dilution), or anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (1/10,000 dilution; Sigma-Aldrich, St. Louis, MO, USA) and the horseradish-peroxidase-conjugated secondary antibody (GE Healthcare UK Ltd., Buckinghamshire, UK)) as described previously [29 (link)]. The protein bands were visualized using Amersham ECL Western Blotting Detection Reagents (GE Healthcare) and a Chemidoc XRS Plus ImageLab System (Bio-Rad).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!